The fixed-dose combination (FDC) therapies were examined both with and without aspirin versus control groups in a combined analysis of more than 18,000 patients without prior CVD from three large clinical trials. FDCs including aspirin cut the risk of heart attacks by 53 per cent, stroke by 51 per cent, and deaths from cardiovascular causes by 49 per cent.

Read More at:

https://health.economictimes.indiatimes.com/news/pharma/researchers-find-combination-therapy-cuts-risk-of-heart-attacks-strokes-in-half/85758204